157 related articles for article (PubMed ID: 2797072)
41. [Analgesic nephropathy].
Pintér I; Nagy J
Orv Hetil; 1998 Nov; 139(47):2839-43. PubMed ID: 9846064
[TBL] [Abstract][Full Text] [Related]
42. Analgesic nephropathy.
Fox JM
N Engl J Med; 1998 Jul; 339(1):49-50; author reply 50. PubMed ID: 9660687
[No Abstract] [Full Text] [Related]
43. Letter: Possible role of laxatives in analgesic nephropathy.
Br Med J; 1975 Apr; 2(5963):140-1. PubMed ID: 1125714
[No Abstract] [Full Text] [Related]
44. In memoriam 'analgesic nephropathy' (circa 1972-2006).
Michielsen P
Nephrol Dial Transplant; 2007 Apr; 22(4):999-1001. PubMed ID: 17213226
[No Abstract] [Full Text] [Related]
45. [Analgesic nephropathy. II. Analgesic nephropathy and analgesic syndrome, diagnosis and treatment].
Vítko S; Prát V; Matousovic K; Dráb K; Horcicková M
Cas Lek Cesk; 1984 Aug; 123(35):1079-82. PubMed ID: 6498898
[No Abstract] [Full Text] [Related]
46. Analgesic nephropathy.
Mathew TH
Aust Fam Physician; 1976 Apr; 5(3):314-23. PubMed ID: 8032
[TBL] [Abstract][Full Text] [Related]
47. Editorial: Analgesic nephropathy: some unsolved problems.
Med J Aust; 1975 Feb; 1(7):185-6. PubMed ID: 1128397
[No Abstract] [Full Text] [Related]
48. Evidence for the nephrotoxicity of analgesics.
Gault MH
Can Med Assoc J; 1972 Oct; 107(8):756-8. PubMed ID: 4638851
[TBL] [Abstract][Full Text] [Related]
49. Analgesic nephropathy.
Wilson DR
Can Med Assoc J; 1972 Oct; 107(8):715-6. PubMed ID: 4638842
[No Abstract] [Full Text] [Related]
50. Regulations controlling the sale of mild analgesics in Canada.
Bishop J; Znamirowska MI; Meltzer AS
Can Med Assoc J; 1972 Oct; 107(8):758 passim. PubMed ID: 4638852
[TBL] [Abstract][Full Text] [Related]
51. Analgesic nephropathy, 1972-76.
Wilson DR; Gault MH
Can Med Assoc J; 1977 Jul; 117(1):16. PubMed ID: 861903
[No Abstract] [Full Text] [Related]
52. Analgesic nephropathy.
Gault MH; Barrett BJ
Am J Kidney Dis; 1998 Sep; 32(3):351-60. PubMed ID: 9740150
[TBL] [Abstract][Full Text] [Related]
53. Nonprescription analgesics.
Hanks GW
Clin Ther; 1983; 5 Suppl B():1-50. PubMed ID: 6354448
[No Abstract] [Full Text] [Related]
54. Analgesic-associated nephropathy. An important cause of renal disease in the United States?
Goldberg M; Murray TG
N Engl J Med; 1978 Sep; 299(13):716-7. PubMed ID: 683257
[No Abstract] [Full Text] [Related]
55. Mechanisms in the development of analgesic nephropathy.
Duggin GG
Kidney Int; 1980 Nov; 18(5):553-61. PubMed ID: 7007712
[No Abstract] [Full Text] [Related]
56. Analgesics and cancers of the renal pelvis and ureter.
Linet MS; Chow WH; McLaughlin JK; Wacholder S; Yu MC; Schoenberg JB; Lynch C; Fraumeni JF
Int J Cancer; 1995 Jul; 62(1):15-8. PubMed ID: 7601560
[TBL] [Abstract][Full Text] [Related]
57. Habitual use of acetaminophen as a risk factor for chronic renal failure: a comparison with phenacetin.
Buckalew VM
Am J Kidney Dis; 1996 Jul; 28(1 Suppl 1):S7-13. PubMed ID: 8669433
[TBL] [Abstract][Full Text] [Related]
58. Analgesic nephropathy in Canada: clinical syndrome, management, and outcome.
Gault MH; Wilson DR
Kidney Int; 1978 Jan; 13(1):58-63. PubMed ID: 713269
[No Abstract] [Full Text] [Related]
59. Personality factors in analgesic nephropathy.
Murray RM
Psychol Med; 1974 Feb; 4(1):69-73. PubMed ID: 4544396
[No Abstract] [Full Text] [Related]
60. Banning phenacetin to prevent analgesic nephropathy?
Pommer W; Molzahn M
Lancet; 1986 Jul; 2(8497):40. PubMed ID: 2873336
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
